Why Five Prime Therapeutics Stock Is Skyrocketing Today

Keith Speights, The Motley Fool
·1-min read
Why Five Prime Therapeutics Stock Is Skyrocketing Today

The huge jump came after Amgen (NASDAQ: AMGN) announced plans to acquire Five Prime for close to $1.9 billion. Regardless, today's announcement is certainly great news for Five Prime Therapeutics shareholders. Investors appear to also think it's a good move for Amgen.